JP2009500310A5 - - Google Patents

Download PDF

Info

Publication number
JP2009500310A5
JP2009500310A5 JP2008518835A JP2008518835A JP2009500310A5 JP 2009500310 A5 JP2009500310 A5 JP 2009500310A5 JP 2008518835 A JP2008518835 A JP 2008518835A JP 2008518835 A JP2008518835 A JP 2008518835A JP 2009500310 A5 JP2009500310 A5 JP 2009500310A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutical composition
composition according
general formula
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008518835A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009500310A (ja
Filing date
Publication date
Priority claimed from DE102005030733A external-priority patent/DE102005030733A1/de
Application filed filed Critical
Publication of JP2009500310A publication Critical patent/JP2009500310A/ja
Publication of JP2009500310A5 publication Critical patent/JP2009500310A5/ja
Pending legal-status Critical Current

Links

JP2008518835A 2005-07-01 2006-06-28 長時間作用性のベータ作用薬と少なくとも1種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物 Pending JP2009500310A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005030733A DE102005030733A1 (de) 2005-07-01 2005-07-01 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
PCT/EP2006/063650 WO2007003554A1 (de) 2005-07-01 2006-06-28 Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen enthaltend langwirksame beta-2-agonisten und wenigstens einen weiteren wirkstoff

Publications (2)

Publication Number Publication Date
JP2009500310A JP2009500310A (ja) 2009-01-08
JP2009500310A5 true JP2009500310A5 (cg-RX-API-DMAC7.html) 2009-08-13

Family

ID=37087177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008518835A Pending JP2009500310A (ja) 2005-07-01 2006-06-28 長時間作用性のベータ作用薬と少なくとも1種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物

Country Status (9)

Country Link
US (1) US20070037781A1 (cg-RX-API-DMAC7.html)
EP (1) EP1901776B1 (cg-RX-API-DMAC7.html)
JP (1) JP2009500310A (cg-RX-API-DMAC7.html)
AR (1) AR054810A1 (cg-RX-API-DMAC7.html)
AT (1) ATE546159T1 (cg-RX-API-DMAC7.html)
CA (1) CA2613828A1 (cg-RX-API-DMAC7.html)
DE (1) DE102005030733A1 (cg-RX-API-DMAC7.html)
TW (1) TW200740440A (cg-RX-API-DMAC7.html)
WO (1) WO2007003554A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035893A1 (en) * 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
WO2010054285A2 (en) * 2008-11-10 2010-05-14 National Health Research Institutes Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
JP2014532063A (ja) * 2011-10-12 2014-12-04 テリジェン リミテッドTeligene Ltd キナーゼ阻害剤としてのキナゾリン誘導体およびその使用方法
CA2950909C (en) * 2014-06-02 2023-03-28 Medicinova, Inc. Method of inhibiting or treating fibrosis
EP3413976A1 (en) * 2016-02-08 2018-12-19 Redx Pharma PLC Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
EP3488851A1 (en) * 2018-10-03 2019-05-29 AVM Biotechnology, LLC Immunoablative therapies

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
CA2341488A1 (en) * 1998-08-26 2000-03-09 Smithkline Beecham Corporation Therapies for treating pulmonary diseases
AU2002214996B2 (en) 2000-10-12 2007-03-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10050995A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CA2450961C (en) 2001-06-22 2010-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
DE10203749A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203741A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203753A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
DK1567139T3 (da) * 2002-11-27 2008-11-03 Nycomed Gmbh Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol
WO2005013994A1 (en) * 2003-07-31 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising anticholinergics and a betamimetic
CA2534693A1 (en) * 2003-08-05 2005-02-17 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising steroids and a betamimetic
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel

Similar Documents

Publication Publication Date Title
JP2007533683A5 (cg-RX-API-DMAC7.html)
ES2399179T3 (es) Tratamiento de enfermedad respiratoria
CA2481468A1 (en) Medicaments containing betamimetic drugs and a novel anticholinesterase drug
CA2439763A1 (en) Pharmaceutical compositions based on anticholinergics and pde-iv inhibitors
CA2477885C (en) Pressurised metered dose inhalers containing solutions of beta-2 agonists
CA2440699A1 (en) Compounds for treating inflammatory diseases
PT1341542E (pt) Derivados idanilo para o tratamento de doenças das vias respiratórias
JP2007517067A5 (cg-RX-API-DMAC7.html)
KR20140012989A (ko) 글리코피롤레이트 및 베타2-효능제의 조합
JP2007500676A5 (cg-RX-API-DMAC7.html)
JP2009513516A (ja) 抗コリン作用薬を含むhfc溶液製剤
WO2020217116A2 (en) Long acting inhalation compositions of indacaterol
JP2015520738A5 (cg-RX-API-DMAC7.html)
JP2009502997A (ja) 噴霧投与用の長時間作用型ベータ2−アゴニストを含む医薬製剤
JP2016532677A5 (cg-RX-API-DMAC7.html)
CA2534120A1 (en) Medicaments for inhalation comprising anticholinergics and a betamimetic
IL155718A (en) Medicament compositions based on tiotropium salts and on salmeterol salts
JP5081158B2 (ja) 呼吸器系疾患治療用の新規な医薬組成物
CN102905694A (zh) 吸入溶液
TWI296934B (en) Inhalable formulation of a solution containing a tiotropium salt
JP2023540171A5 (cg-RX-API-DMAC7.html)
US20150366804A1 (en) Pharmaceutical Compositions Comprising Multi-Component Crystalline Particles Suitable for Use in Inhalation Therapy
PE20040326A1 (es) Medicamento que contiene esteroides y un nuevo anticolinergico
CA2534128A1 (en) Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
JP2009537585A (ja) 呼吸器疾患の治療のための新規医薬組成物